Exane BNP Paribas re-initiated coverage of ASML (ASML) with an Outperform rating and $858 price target It is time for investors to revisit the long-term ASML story, the analyst tells investors in a research note. The firm expects the company to hit the upper end of its 2023 guidance and see 6% upside to 2030 sales estimates. ASML has the “widest moat” in semis and is the “brains behind the brains” of artificial intelligence, contends Exane.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ASML:
- ASML expects impact of updated export restrictions to fall within 2025 outlook
- ASML call volume above normal and directionally bullish
- U.S. Enacts Toughest Chip Export Controls to Curb China’s AI Ambitions
- ASML price target lowered to $767 from $815 at Bernstein
- Chip Stocks Gain as U.S. Could Soften Stance on China Sanctions
Questions or Comments about the article? Write to editor@tipranks.com